Daniel Charles Chambers
Rank 42 by 10-year citations to CLAD papers (14 papers, 518 citations). "Pre-Eminent consultant" (Thoracic & Transplant Physician, The Prince Charles Hospital); field: transplant medicine.
As of . Primary source: ORCID record (role and affiliation entries are self-asserted).
Summary
Daniel Charles Chambers. Role: ORCID lists "Pre-Eminent consultant" (Thoracic & Transplant Physician, The Prince Charles Hospital); "Head of Research" (Division of UQ Thoracic Research Centre, Queensland Lung Transplant Service). Basis of the role: ORCID employment entries without an end date (self-asserted by the record holder, may be out of date). Field indicated by the unit name: transplant medicine (source: the same ORCID entries). Affiliation: The Prince Charles Hospital, Brisbane (AU); Queensland Lung Transplant Service, Brisbane (AU). Basis: ORCID record, employment entries without an end date (self-asserted, may be out of date). Counts in the OpenAlex corpus (retrieved 2026-10-10): 14 papers and 518 citations over ten years; 2 first-author and 5 last-author papers. Ranks: main 42, excluding consensus papers 31, first or last author 69. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.
Citation ranks (10 years)
| Main rank | Rank excluding consensus papers | Rank by first or last author papers |
|---|---|---|
| 42 of 800 | 31 of 794 | 69 of 512 |
Citations: 518 in total, 518 excluding consensus and guideline papers (0 of this author's papers excluded), 120 on first or last author papers (2 first, 5 last).
Ranking method: see the methodology note at the top of the People list and the full methodology document.
Role and field
- Role
- "Pre-Eminent consultant" (Thoracic & Transplant Physician, The Prince Charles Hospital); "Head of Research" (Division of UQ Thoracic Research Centre, Queensland Lung Transplant Service)
- Role status
- verified from ORCID (self-asserted entries; may be out of date)
- Role basis
- ORCID employment entries without an end date (self-asserted by the record holder, may be out of date)
- Field
- transplant medicine
- Field basis
- the same ORCID entries
Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.
Details
- affiliation
- The Prince Charles Hospital, Brisbane (AU); Queensland Lung Transplant Service, Brisbane (AU)
- papers 10y
- 14
- fractional papers 10y
- 1.48
- citations 10y
- 518
- fractional citations 10y
- 45.6
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0002-9553-5870
- openalex author id
- A5039211752
- merged open alex profiles
- 1
- affiliation basis
- ORCID record, employment entries without an end date (self-asserted, may be out of date)
- papers excluding consensus 10y
- 14
- citations excluding consensus 10y
- 518
- consensus papers excluded 10y
- 0
- first author papers 10y
- 2
- last author papers 10y
- 5
- lead author citations 10y
- 120
- lead author papers 10y
- 7
Sources and links
- ORCID record (role and affiliation entries are self-asserted) (primary)
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Bronchiolitis obliterans syndrome–free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis (The Journal of Heart and Lung Transplantation, 2019); 134 citations; DOI 10.1016/j.healun.2018.09.016
- Most-cited CLAD paper in corpus: Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study (Stem Cells Translational Medicine, 2017); 89 citations; DOI 10.1002/sctm.16-0372
- Most-cited CLAD paper in corpus: The Assist CLAD Study - Mesenchymal Stromal Cell Therapy in Chronic Lung Allograft Dysfunction (The Journal of Heart and Lung Transplantation, 2024); 1 citations; DOI 10.1016/j.healun.2024.02.016
- Most-cited CLAD paper in corpus: Lysophosphatidic Acid Drives Recruitment and Fibroblastic Differentiation of Mesenchymal Stromal Cells in Chronic Lung Allograft Dysfunction (The Journal of Heart and Lung Transplantation, 2018); 0 citations; DOI 10.1016/j.healun.2018.01.081
- Most-cited CLAD paper in corpus: Longitudinal Increases in Bronchoalveolar Lavage Interleukin-6, Interleukin-8, Macrophage Inflammatory Protein-1a, and Transforming Growth Factor ß Predict Progressive Chronic Lung Allograft Dysfunction (The Journal of Heart and Lung Transplantation, 2024); 0 citations; DOI 10.1016/j.healun.2024.02.425
- ORCID employment entries (source of the role)
Known gaps in this record
- centre membership relation (not asserted)
- funding and conflicts of interest
- only the top-30 entries were checked by hand for ID merges and splits
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.